Australie - anglais - Department of Health (Therapeutic Goods Administration)

boucher & muir pty ltd - ursodeoxycholic acid, quantity: 250 mg - capsule, hard - excipient ingredients: maize starch; colloidal anhydrous silica; pregelatinised maize starch; magnesium stearate; titanium dioxide; gelatin; sodium lauryl sulfate; sorbitan monolaurate - ursosan is indicated in the treatment of chronic cholestatic liver diseases.

Australie - anglais - Department of Health (Therapeutic Goods Administration)

dr falk pharma australia pty ltd - ursodeoxycholic acid, quantity: 250 mg - capsule, hard - excipient ingredients: colloidal anhydrous silica; titanium dioxide; maize starch; gelatin; sodium lauryl sulfate; magnesium stearate; purified water - the treatment of chronic cholestatic liver diseases.

Israël - anglais - Ministry of Health

cts chemical industries ltd, israel - ursodeoxycholic acid - tablets - ursodeoxycholic acid 100 mg - ursodeoxycholic acid - ursodeoxycholic acid - dissolution or reductin in size of radiolucent cholesterol in patient with a functioning gallbladder. treatment of chronic liver diseases including primary billiary cirrhosis, primary sclerosing cholangitis, cystic fibrosis associated liver disease, biliary atresia, chronic hepatitis, and alcohol cirrhosis.

Israël - anglais - Ministry of Health

cts chemical industries ltd, israel - ursodeoxycholic acid - tablets - ursodeoxycholic acid 300 mg - ursodeoxycholic acid - ursodeoxycholic acid - dissolution or reduction in size of radiolucent cholesterol gallstones in patients with a functioning gallbladder. treatment of chronic liver diseases including primary biliary cirrhosis, primary sclerosing cholangitis, cystic fibrosis associated liver disease, biliary atresia chronic hepatitis and alcoholic cirrhosis.

Israël - anglais - Ministry of Health

rafa laboratories ltd - ursodeoxycholic acid - film coated tablets - ursodeoxycholic acid 500 mg - ursodeoxycholic acid - ursodeoxycholic acid - for the symptomatic treatment of primary biliary cirrhosis (pbc), in patients without decompensated hepatic cirrhosis.

Australie - anglais - Department of Health (Therapeutic Goods Administration)

generic health pty ltd - ursodeoxycholic acid, quantity: 250 mg - capsule, hard - excipient ingredients: maize starch; magnesium stearate; colloidal anhydrous silica; titanium dioxide; sorbitan monolaurate; gelatin; sodium lauryl sulfate - ursodox lupin (ursodeoxycholic acid) capsule is indicated in the treatment of chronic cholestatic liver diseases.

Australie - anglais - Department of Health (Therapeutic Goods Administration)

generic health pty ltd - ursodeoxycholic acid, quantity: 250 mg - capsule, hard - excipient ingredients: colloidal anhydrous silica; maize starch; magnesium stearate; titanium dioxide; iron oxide yellow; gelatin - ursodox lapl (ursodeoxycholic acid) capsule is indicated in the treatment of chronic cholestatic liver diseases.

Malte - anglais - Medicines Authority

central procurement & supplies unit - ursodeoxycholic acid - hard capsule - ursodeoxycholic acid 250 milligram(s) - bile and liver therapy

Malte - anglais - Medicines Authority

central procurement & supplies unit ub002 industrial estate, san gwann sgn 3000, malta - ursodeoxycholic acid - hard capsule - ursodeoxycholic acid 250 mg - bile and liver therapy

Malte - anglais - Medicines Authority

cherubino limited delf building, sliema road, gzira, gzr 1637, malta - ursodeoxycholic acid - hard capsule - ursodeoxycholic acid 250 mg - bile and liver therapy